Superiority of yeast over bacterial cytosine deaminase for enzyme/prodrug gene therapy in colon cancer xenografts

Cancer Research

Volumn 59, Issue 7, 1999, Pages 1417-1421

  Kievit, Els ^a   Bershad, Eric ^a   Ng, Emily ^a   Sethna, Phiroze ^b   Dev, Inderjeet ^b   Lawrence, Theodore S ^a   Rehemtulla, Alnawaz ^a,c  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b GLAXOSMITHKLINE   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSINE DEAMINASE; FLUCYTOSINE; PRODRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLON CANCER; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; DRUG EFFICACY; ENZYME ACTIVITY; ENZYME PURIFICATION; GENE THERAPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TREATMENT OUTCOME; TUMOR REGRESSION; TUMOR XENOGRAFT;

EID: 0033119291     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Vauthey, J. N., de Marsh, R., Cendan, J. C., Chu, N. M., and Copeland, E. M. Arterial therapy of hepatic colorectal metaslases. Br. J. Surgery, 83: 447-455, 1996.
2. Huber, B. E., Austin, E. A., Good, S. S., Knick, V. C., Tibbels, S., and Richards, C. A. In vivo antitumor activity of 5-fluorocytosine on human colorectal carcinoma cells genetically modified to express cytosine deaminase. Cancer Res., 53: 4619-4626, 1993.
3. Trinh, Q. T., Austin, E. A., Murray, D. M., Knick, V. C., and Huber, B. E. Enzyme/prodrug gene therapy: comparison of cytosine deaminase/5-fluorocytosine versus thymidine kinase/ganciclovir enzyme/prodrug systems in a human colorectal carcinoma cell line. Cancer Res., 55: 4808-4812, 1995.
4. Hirschowitz, E. A., Ohwada, A., Pascal, W. R., Russi, T. J., and Crystal, R. G. In vivo adenovirus-mediated gene transfer of the Escherichia coli cytosine deaminase gene to human colon carcinoma-derived tumors induced chemosensitivity to 5-fluorocytosine. Hum. Gene Ther., 6: 1055-1063, 1995.
5. Ohwada, A., Hirschowitz, E. A., and Crystal, R. G. Regional delivery of an adenovirus vector containing the Escherichia coli cytosine deaminase gene to provide local activation of 5-fluorocytosine to suppress the growth of colon carcinoma metastatic to liver. Hum. Gene Ther., 7, 1567-1576, 1996.
6. Mullen, C. A., Coale, M. M., Lowe, R., and Blaese, R. M. Tumors expressing the cytosine deaminase suicide gene can be eliminated in vivo with 5-fluorocytosine and induce protective immunity to wild type tumor. Cancer Res., 54: 1503-1506, 1994.
7. Rogulski, K. R., Zhang, K., Kolozsvary, A., Kim, J. H., and Freytag, S. O. Pronounced antitumor effects and tumor radiosensitization of double suicide gene therapy. Clin. Cancer Res., 3: 2081-2088, 1997.
8. Evoy, D., Hirschowitz, E. A., Naama, H. A., Li, X. K., Crystal, R. G., Daly, J. M., and Lieberman, M. D. In vivo adenoviral-mediated gene transfer in the treatment of pancreatic cancer. J. Surg. Res., 69: 226-231, 1997.
9. West, T. P., Shanley, M. S., and O'Donovan, G. A. Purification and some properties of cytosine deaminase from Salmonella typhimurium. Biochim. Biophys. Acta. 719: 251-258, 1982.
10. Katsuragi, T., Sonoda, T., Matsumoto, K., Sakai, T., and Tonomura, K. Purification and some properties of cytosine deaminase from baker's yeast. Agric. Biol. Chem., 53: 1313-1319, 1989.
11. Lawrence, T. S., Rehemtulla, A., Ng, E. Y., Wilson, M., Trosko, J. E., and Stetson, P. L. Preferential cytotoxicity of cells transduced with cytosine deaminase compared with bystander cells after treatment with 5-flucytosine. Cancer Res., 58: 2588-2593, 1998.
12. Erbs, P., Exinger, F., and Jund, R. Characterization of the Saccharomyces cerevisiae FCY1 gene encoding cytosine deaminase and its homologue FCA1 of Candida albicans. Curr. Genet., 31: 1-6, 1997.
13. Smith, D. B., and Johnson, K. S. Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene, 67: 31-40, 1988.
14. Richards, C. A., Austin, E. A., and Huber, B. E. Transcriptional regulatory sequences of carcinoembryonic antigen: identification and use with cytosine deaminase for tumor-specific gene therapy. Hum. Gene. Ther., 6: 881-893, 1995.
15. Senter, P. D., Su, P. C. D., Katsuragi, T., Sakai, T., Cosand, W. L., Hellstrom, I., and Hellstrom, K. E. Generation of 5-fluorouracil from 5-fluorocytosine by monoclonal antibody-cytosine deaminase conjugates. Bioconjugate Chem., 2: 447-451, 1991.
16. Lawrence, T. S. Reduction of doxorubicin cytotoxicity by ouabain: correlation with topoisomerase-induced DNA strand breakage in human and hamster cells. Cancer Res., 48: 725-730, 1988.
17. Austin, E. A., and Huber, B. E. A first step in the development of gene therapy for colorectal carcinoma: cloning, sequencing, and expression of Escherichia coli cytosine deaminase. Mol. Pharmacol., 43: 380-387, 1993.
18. Katsuragi, T., Sakai, T., Matsumoto, K., and Tonomura, K. Cytosine deaminase from Escherichia coli - production, purification and some characteristics. Agric. Biol. Chem., 50: 1721-1730, 1986.
19. Huber, B. E., Austin, E. A., Richards, C. A., Davis, S. T., and Good, S. S. Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase. Proc. Natl. Acad. Sci. USA, 91: 8302-8306, 1994.
20. McGinn, C. J., Shewach, D. S., and Lawrence, T. S. Radiosensitizing nucleosides. J. Natl. Cancer Inst., 88: 1193-1203, 1996.
21. Khil, M. S., Kim, J. H., Mullen, C. A., Kim, S. H., and Freytag, S. O. Radiosensitization by 5-fluorocytosine of human colorectal carcinoma cells in culture transduced with cytosine deaminase gene. Clin. Cancer Res., 2: 53-57, 1996.
22. Hanna, N. N., Mauceri, H. J., Wayne, J. D., Hallahan, D. E., Kufe, D. W., and Weichselbaum, R. R. Virally directed cytosine deaminase/5-fluorocytosine gene therapy enhances radiation response in human cancer xenografts. Cancer Res., 57: 4205-4209, 1997.
23. Pederson, L. C., Buchsbaum, D. J., Vickers, S. M., Kancharla, S. R., Mayo, M. S., Curiel, D. T., and Stackhouse, M. A. Molecular chemotherapy combined with radiation therapy enhances killing of cholangiocarcinoma cells in vitro and in vivo. Cancer Res., 57: 4325-4332, 1997.